Please try another search
Syncona Limited is a Guernsey-based closed-ended investment company. The Company is a healthcare company focused on founding, building and funding a portfolio of life science companies. The Company’s investment objective is to achieve superior long-term capital appreciation from its investments. The Company invests in life science businesses (including private and quoted companies) and single or multi-asset projects (Life Science Investments). Syncona Investment Management Limited (SIML), acts as the Company’s alternative investment fund manager (investment manager).
Name | Age | Since | Title |
---|---|---|---|
Nicholas David Moss | 64 | 2012 | Senior Independent Director |
Nigel John Keen | - | 2016 | Non-Executive Director |
Robert Anthony Hutchinson | - | 2017 | Non-Executive Director |
Gian Piero Reverberi | 57 | 2018 | Non-Executive Director |
Thomas Henderson | 57 | 2012 | Co-Founder & Non-Executive Director |
Kemal Malik | 61 | 2020 | Non-Executive Director |
Melanie Gee | 61 | 2019 | Chairman |
Virginia Anne Holmes | 62 | 2021 | Non-Executive Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review